Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patients
    • Disease patterns
    • Diagnostics
    • Therapy
  • Partner Content
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
    • Gastroenterology
      • IBD matters
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
  • Departments
    • Allergology and clinical immunology
    • General Internal Medicine
    • Anesthesiology
    • Angiology
    • Surgery
    • Dermatology and venereology
    • Endocrinology and Diabetology
    • Nutrition
    • Gastroenterology and Hepatology
    • Genetics
    • Geriatrics
    • Gynecology
    • Hematology
    • Infectiology
    • Cardiology
    • Nephrology
    • Neurology
    • Emergency and intensive care medicine
    • Nuclear Medicine
    • Oncology
    • Ophthalmology
    • ORL
    • Orthopedics
    • Pediatrics
    • Pharmacology and toxicology
    • Pharmaceutical medicine
    • Phlebology
    • Physical medicine and rehabilitation
    • Pneumology
    • Prevention and health care
    • Psychiatry and psychotherapy
    • Radiology
    • Forensic Medicine
    • Rheumatology
    • Sports Medicine
    • Traumatology and trauma surgery
    • Tropical and travel medicine
    • Urology
    • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
  • Log In
  • Register
  • My account
  • Contact
  • Publications
  • Contact
  • Deutsch
  • English
  • Français
  • Italiano
  • Português
  • Español
Subscribe
Medizinonline Medizinonline
Medizinonline Medizinonline
  • News
    • News
    • Market & Medicine
  • Patienten
    • Krankheitsbilder
    • Diagnostik
    • Therapie
  • Partner Content
    • Diabetes
      • Dia-Month Club – Type 2 Diabetes
      • Diabetes in Motion
    • Gastroenterology
      • IBD matters
    • Oncology
      • Swiss Oncology in motion
    • Orthopedics
      • Osteoporosis in motion
    • Phytotherapie
    • Rheumatology
  • Departments
    • Fachbereiche 1-13
      • Allergology and clinical immunology
      • General Internal Medicine
      • Anesthesiology
      • Angiology
      • Surgery
      • Dermatology and venereology
      • Endocrinology and Diabetology
      • Nutrition
      • Gastroenterology and Hepatology
      • Genetics
      • Geriatrics
      • Gynecology
      • Hematology
    • Fachbereiche 14-26
      • Infectiology
      • Cardiology
      • Nephrology
      • Neurology
      • Emergency and intensive care medicine
      • Nuclear Medicine
      • Oncology
      • Ophthalmology
      • ORL
      • Orthopedics
      • Pediatrics
      • Pharmacology and toxicology
      • Pharmaceutical medicine
    • Fachbereiche 26-38
      • Phlebology
      • Physical medicine and rehabilitation
      • Phytotherapy
      • Pneumology
      • Prevention and health care
      • Psychiatry and psychotherapy
      • Radiology
      • Forensic Medicine
      • Rheumatology
      • Sports Medicine
      • Traumatology and trauma surgery
      • Tropical and travel medicine
      • Urology
      • Dentistry
  • CME & Congresses
    • CME continuing education
    • Congress Reports
    • Congress calendar
  • Practice
    • Noctimed
    • Practice Management
    • Jobs
    • Interviews
Login

Sie haben noch keinen Account? Registrieren

  • Coronary heart disease (CHD)

Blood pressure reduction – how deep is deep enough?

    • Cardiology
    • Education
    • RX
  • 2 minute read

Coronary artery disease correlates closely with arterial hypertension. Therefore, to prevent damage to the left ventricular myocardium or the risk of stroke, blood pressure should be lowered. Only how far?

CHD and arterial hypertension are closely associated and may result in left ventricular myocardial damage. In addition, inadequately treated high blood pressure can also significantly increase the risk of stroke and kidney failure. The target is therefore a blood pressure below 140 mmHg/90 mmHg. However, many patients do not reach this value. In this context, one study found that patients with moderate cardiovascular risk in particular benefit significantly from blood pressure values below 130 mmHg systolic [2]. Reason enough for the American professional societies to adapt their guidelines accordingly. Since 2017, the American College of Cardiology guidelines have included an additional hypertension category, Stage 1 Hypertension. Accordingly, patients should already be treated at levels of 130-139 mmHg/80-89 mmHg [3].

However, not all experts share this attitude. Germany and Europe in particular are critical of the implementation of such low values. One reason is the particular patient profile of the study. High-risk patients with diabetes or a history of stroke were not studied. There is preliminary evidence that there may be a resurgence of cardiovascular events in certain patients when pressure falls below 120 mmHg.

The main point of criticism, however, lies in the blood pressure measurement itself. The measurements were carried out unattended, so that the “white coat effect” was absent. Therefore, incorrect, higher measured values may occur in everyday practice. Prof. Schunkert, Munich, also warns patients with CHD to be particularly cautious: “Too drastic a reduction with diastolic values below 60 mmHg can be problematic for patients with CHD because blood flow to the coronary vessels can be jeopardized, especially if constrictions are still present.” [4].

 

Literature:

  1. Busch M, Kuhnert R: Journal of Health Monitoring 2017; 2(1): 64-69.
  2. The SPRINT Research Group: N Engl J Med. 2015; 373: 2103-2116.
  3. Atasoy S, et al: European Heart Journal 2018.
  4. www.herzstiftung.de/sprint-studie-blutdruck-wie-tief-senken.html (last access: 01/26/2019)

 

CARDIOVASC 2019; 18(1): 32

Autoren
  • Leoni Burggraf
Publikation
  • CARDIOVASC
Related Topics
  • Blood pressure
  • CHD
  • coronary heart disease
  • Hypertension
Previous Article
  • Annual Meeting of the Swiss Brain Stroke Society, Zurich

PCSK9 inhibitors keep acute coronary syndrome at bay

  • Cardiology
  • Congress Reports
  • RX
  • Studies
View Post
Next Article
  • Left ventricular assist device (LVAD)

Heart failure: who benefits from mechanical circulatory support

  • Cardiology
  • Education
  • RX
  • Studies
  • Surgery
View Post
You May Also Like
View Post
  • 4 min
  • From symptom to diagnosis

Pulmonology – Lobus venae acygos

    • RX
    • Cases
    • Education
    • Oncology
    • Pneumology
    • Radiology
View Post
  • 9 min
  • Atopic Dermatitis: Precisely Targeting Immunological Targets

Interleukin blockade or OX40-(L) inhibition?

    • RX
    • Allergology and clinical immunology
    • Dermatology and venereology
    • Education
    • Studies
View Post
  • 14 min
  • Fibromyalgia Syndrome

Development, Diagnosis, Epidemiology, and Treatment of a Disease Entity

    • General Internal Medicine
    • CME continuing education
    • Geriatrics
    • Neurology
    • Orthopedics
    • Rheumatology
    • RX
View Post
  • 27 min
  • Across All Types of Cancer

Four-Legged Medical Assistants – Therapy Dogs in Clinical Settings

    • RX
    • CME continuing education
    • General Internal Medicine
    • Geriatrics
    • Hematology
    • Oncology
    • Pediatrics
    • Physical medicine and rehabilitation
    • Prevention and health care
    • Studies
View Post
  • 8 min
  • Obesity: More than half of those affected have fatty liver disease

From screening to multimodal intervention with GLP-1-RA or resmetirom

    • RX
    • Education
    • Endocrinology and Diabetology
    • Gastroenterology and Hepatology
    • General Internal Medicine
    • Nutrition
    • Studies
View Post
  • 6 min
  • Innovative Oral Treatment Options for Psoriasis: Icotrokinra and Zasocitinib

First-class immunomodulation combined with convenience—the data available so far is convincing

    • RX
    • Congress Reports
    • Dermatology and venereology
    • Rheumatology
    • Studies
View Post
  • 4 min
  • Preclinical Study on a Special Ginkgo biloba Extract

What role do proanthocyanidins play?

    • RX
    • Education
    • General Internal Medicine
    • Geriatrics
    • Neurology
    • Pharmaceutical medicine
    • Pharmacology and toxicology
    • Phytotherapy
    • Studies
View Post
  • 6 min
  • Myasthenia gravis: immunomodulatory therapies for long-term treatment

Expanded Possibilities Thanks to Innovative Classes of Active Ingredients

    • RX
    • Congress Reports
    • General Internal Medicine
    • Neurology
    • Ophthalmology
    • Studies
  • IBD matters

    Zum Thema
Top CME content
  • 1
    Four-Legged Medical Assistants – Therapy Dogs in Clinical Settings
  • 2
    Functional limb preservation between infection control, vascular medicine and resurfacing
  • 3
    Update on Idiopathic Pulmonary Fibrosis
  • 4
    Update on Idiopathic Pulmonary Fibrosis
  • 5
    Current status of PAT

Newsletter

Sign up and stay up to date

Subscribe
Medizinonline Medizinonline
  • Contact
  • General terms and conditions
  • Imprint

Input your search keywords and press Enter.